Ark Genomic Revolution Multi-Sector ETF (ARKG)
$36.41 0.73 (1.97%)
18:10 EST ARKG Stock Quote Delayed 15 Minutes
Previous Close $36.41
Market Cap 116.70M
PE Ratio -
Volume (Avg. Vol.) 240,800
Day's Range 36.15 - 36.99
52-Week Range 27.62 - 37.92
Dividend & Yield N/A (N/A)
ARKG Stock Predictions, Articles, and Ark Genomic Revolution Multi-Sector ETF News
- From InvestorPlace
- From the Web
Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.
We have highlighted four sector ETFs that easily crushed the market in August and could be better plays in the months ahead should the trends prevail. Compare B....
We have highlighted four sector ETFs that have gained handsomely in May and could be better plays in the months ahead should the trends prevail. Compare Brokers....